Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- Submitting institution
-
The University of Leicester
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 2307
- Type
- D - Journal article
- DOI
-
10.1056/NEJMoa2022190
- Title of journal
- New England Journal of Medicine
- Article number
- .
- First page
- 1413
- Volume
- 383
- Issue
- 15
- ISSN
- 0028-4793
- Open access status
- Exception within 3 months of publication
- Month of publication
- August
- Year of publication
- 2020
- URL
-
https://www.nejm.org/doi/10.1056/NEJMoa2022190
- Supplementary information
-
https://doi.org/10.1056/NEJMoa2022190
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
38
- Research group(s)
-
A - Cardiovascular
- Citation count
- 176
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a significant contribution to the organisation of the conduct of the study, and to carrying out the study. The author helped both draft the output, and critique the output for important intellectual content.
- Non-English
- No
- English abstract
- -
